mortality/aging
• following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre), mice show 50% survival at 63 weeks compared to 38 weeks in single Kras heterozygous controls, indicating an 83% increase in survival
|
neoplasm
• tumor burden is reduced compared to single Kras heterozygotes; tumors that are found express Raf1
|